Singapore’s largest healthcare group parters with Delmege Medical

Singapore’s largest integrated healthcare provider and leading international group, Sing Health which has two tertiary – level hospitals and five specialty centres, has tied up with Delmege Medical (Pvt) Ltd, a part of the Delmege Forsyth Group which has been in existence for over 150 years, where Delmege Medical will be the local representative for SingHealth in Sri Lanka.

Delmege Medical Director, Kavinda Makalande said: “As its local representative Delmege Medical will offer required patient information about medical treatment at any SingHealth facility to all its local customers who wish to be treated by the SingHealth group of hospitals by calling over at its office at 101, Vinayalankara Mawatha or calling on its hot line 0117729287 or 0117729247. We will also facilitate the process and extend all help to those who wish to avail themselves of this service.”

The two tertiary level hospitals within the SingHealth Group are Singapore General Hospital and KK Women’s and Children’s Hospital. The Specialty Centres are respectively the National Cancer Institute Singapore, National Heart Centre Singapore, National Neuroscience Institute, Singapore National Eye Centre and the National Dental Centre Singapore.  

SingHealth Institutions are equipped with highly advanced medical technology and offer pioneering treatment in a wide range of medical procedures, with outcomes comparable with the best institutions worldwide. With over 40 Specialists and a faculty of 1000 internationally recognised and qualified medical practitioners, SingHealth offers multi disciplinary, integrated care and is recognised for new breakthrough treatment in the region. Each year SingHealth performs over 200,000 surgeries and handles about 4.5 million patient visits.

SingHealth was the first healthcare facility in Asia Pacific to use 3D Fluoroscopy with stealth navigation (Medtronic O–arm), while the Singapore General Hospital offers spine and orthopaedic patients less invasive surgery, faster recovery time and improved out come. The Singapore General Hospital has also performed the world’s first unrelated cord blood stem cell transplant as well as the first cord blood transplant for Thalassaemia patients.

The Breast Centre at the KK Women’s and Children’s Hospital, was the first in the world to use FDA approved Computed Radiography for phosphor plate mammography, while it is the largest Cancer Centre in Southeast Asia with a cure rate of 80 per cent for acute lymphoblastic leukemia.

At the National Cancer Centre Singapore, a first in-man-allogenic stem cell transplant for advanced nasopharyngeal cancer is in near completion and shows encouraging results with acceptable toxicity in 20 heavily pre-treated patients.

The National Heart Centre Singapore performed one of the world’s first veno-venous Extracorporeal Membrane Oxygenation (ECMO)for support of airways obstruction for mediastinal lymphoma.

The Singapore Eye Care Centre is a world pioneer in conjunctival stem Cell transplant.

Driven by the neuroscience expertise of the National Neuroscience Institute, the world’s first Integrated National Neuroscience Centre located at the Singapore General Hospital, provides high quality imaging modalities for accurate diagnosis for all complicated surgeries.

According to Makalande, Delmege Medical would be providing a wide array of services to ensure the highest standards in meeting the healthcare needs of those patient who will be referred for treatment at SingHealth.  “ We will also be arranging a medical session to mark our association with SingHealth which will be attended by prominent Orthopaedic surgeons from Singapore General Hospital, namely Prof Boon Keng and Assistant Prof Andrew Tan Hwee Chye, who along with Dr.Benjamin Soo Yeng Chuawho who is a well-known Vascular & Endovascular Surgeon, will be the keynote speakers.”